NetworkNewsBreaks – Heat Biologics (NASDAQ: HTBX) Receives Grant to Develop Zika Vaccine
Heat Biologics, Inc. (NASDAQ: HTBX) this morning said Natasa Strbo, M.D., D.Sc., research assistant professor of Microbiology and Immunology at the University of Miami Miller School of Medicine, has received a three-year $981,901 grant from the Florida Department of Health 2016-17 Zika Research Grant Initiative to further develop and test the gp96-based Zika vaccine. The vaccine is being developed under a collaboration between the University of Miami and Heat’s wholly owned subsidiary, Zolovax, Inc., which has licensed the patent. The grant is expected to cover the preclinical development of the Zika vaccine, and allow Dr. Strbo to expand her laboratory…







